NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 231 participants.
Also called NCT02483143
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 231 participants
- Sponsor
- Karadeniz Technical University
- Registry
-
NCT02483143
-
- Other papers using this trial's data
- The High Risk of Contrast-induced Nephropathy in Patients with Suspected Pulmonary Embolism Despite Three Different Prophylaxis: A Randomized Controlled Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Türkiye
- Registry status
- Completed
Technical summary
Registry record NCT02483143. Randomized; triple masking; primary purpose prevention. Start 2014-02 (registry gives no type); primary completion 2015-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial
- Condition
- Radiographic Contrast Agent Nephropathy
- Condition
- Pulmonary Embolism
- Intervention (Drug)
- NAC
- Intervention (Drug)
- NaHCO3
- Intervention (Drug)
- Normal Saline
- Lead sponsor
- Karadeniz Technical University
Record details
- Record id
cardio:ct-nct02483143- Content hash
ff731ee7486fac690ee223595389805cfb3edffac13ea4644d6218433a96e16e